StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) stock

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.04−0.02 (-0.82%)

Close on Nov 19, 2026Market cap $480.55KP/E –Yield –

Clearmind Medicine free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2022 it was -$3.73M.

Annual free cash flow

PeriodPeriod endValueChange
FY2022Oct 31, 2022-$3.73M–
FY2021Oct 31, 2021-$2.09M–

More Clearmind Medicine figures

See a number that looks wrong?